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Introduction
•	 Pain	Control	following	total	joint	arthroplasty	(TJA)	re-
mains	challenging	and	often	requires	opioid	analgesics.
•	 Opioids	have	side	effects	that	may	affect	patient	recov-
ery
•	 Use	of 	Extended	Release	Epidural	Morphine	(EREM)	
has	been	shown	to	reduce	average	supplemental	oral/
IV	opioid	morphine	equivalent	usage	.
•	 EREM	has	also	been	shown	to	have	superior	analgesic	
efficacy	over	other	modes	of 	post	operative	pain	man-
agement.	-5
Method
•	 Study	consists	of 	206	randomly	selected	patients	re-
ceiving	total	hip	arthroplasty	or	total	knee	arthroplasty	
between	January	and	July	of 	2007.
•	 Patients	were	chosen	based	on	different	postoperative	
analgesic	modalities:
•	 Patient	information	was	extracted	from	medical	records	
and	gathered	in	a	database.		
•	 Incidences	of 	side	effects	were	recorded	on	post		
operative	day	zero,	one,	and	two.
•	 Side	effects	were	determined	by	administration	of 		
treatment	medications.
•	 Time	interval	from	spinal,	combined	spinal	epidural,	or	
EREM	to	first	dose	of 	side	effect	treatment	was		
recorded.
•	 Side	effects	recorded	include:
	 o	 Pruritus
	 o	 Nausea/vomiting
	 o	 Respiratory	depression	
Discussion:
•	 All	modalities	produced	peak	side	effects	on	day	zero,	
which	declined	over	the	next	24	hours.
•	 Intensity	of 	side	effects	was	not	graded,	hence	the		
incidence	of 	side	effects	may	appear	greater	than		
expected.
•	 EREM	had	a	similar	side	effect	profile	to	IT	morphine	
with	PCA.
•	 Majority	of 	patients	responded	to	a	single	rescue	dose	
for	pruritus	and	nausea.	
•	 No	patient	in	any	group	experienced	respiratory		
depression	requiring	pharmacologic	intervention	in	this	
study.
•	 Opioid	related	side	effects	associated	with	EREM	were	
similar	to	other	analgesic	modalities	and	generally		
responded	to	single-dose	treatment.
Conclusion:
•		Given	the	previously	demonstrated	efficacy	of 	EREM	
and	a	side	effect	profile	similar	to	other	modalities,	
EREM	may	offer	greater	patient	comfort	and	reduce	
utilization	of 	healthcare	resources.	
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Comparison of Side Effects with Extended Release Epidural Morphine and  
Other Analgesic Modalities
Introduction: 
Opioids	are	the	mainstay	of 	post-operative	pain	management	and	may	produce	
side	 effects	 that	 impact	 patient	 recovery.	 Use	 of 	 Extended	 Release	 Epidural	
Morphine	 (EREM)	 has	 been	 shown	 to	 result	 in	 significantly	 less	 average	
morphine	usage	 and	 to	have	 superior	 analgesic	 efficacy	 than	other	modes	of 	
postoperative	pain	management.	The	purpose	of 	this	retrospective	review	was	
to	compare	the	incidence	and	onset	of 	side	effects	of 	EREM	and	other	post-
operative	analgesic	regimens.
Method: 
This	 was	 a	 retrospective,	 IRB	 approved	 analysis	 of 	 206	 randomly	 selected	
patients	 receiving	 unilateral	 hip	 (THA)	 or	 knee	 arthroplasty	 (TKA)	 between	
January	 2007	 and	 July	 2007.	 119	 patients	 received	 lower	 than	 recommended	
doses	of 	EREM.	87	received	one	of 	the	following	analgesic	regimens:	patient	
controlled	analgesia	(PCA)	with	fentanyl,	intrathecal	(IT)	morphine	and	fentanyl	
PCA,	 indwelling	 epidural	 catheter	with	 0.2	%	 ropivacaine	 and	 fentanyl	 PCA,	
or	femoral	nerve	block	(FNB)	and	fentanyl	PCA.	The	incidence	of 	opioid	side	
effects	 on	 post	 operative	 day	 (POD)	 0,	 1,	 &	 2	 was	 recorded.	 Nausea/	
vomiting	 and	 pruritus	 were	 identified	 by	 the	 administration	 of 	 treatment	
medication.	Time	 interval	between	spinal,	CSE,	or	EREM	administration	and	
first	dose	of 	side	effect	treatment	was	also	noted.	Standard	error	of 	the	mean	
(SEM)	and	two-tailed	ANOVA	with	α=0.05	was	performed	on	average	time	to	
first	dose	of 	treatment	between	groups	of 	analgesic	modalities.
Results: See Tables 1 and 2
Discussion:
All	 analgesic	 modalities	 produced	 peak	 side	 effects	 on	 day	 zero	 which	 then	
declined	over	 the	next	24	hours.	The	occurrence	of 	side-effects	was	reported	
by	a	request	for	treatment.	The	intensity	of 	side	effects	was	not	graded.	Hence	
the	incidence	of 	side	effects	may	appear	higher	than	expected.	Although	EREM	
caused	more	side	effects	than	some	other	modalities	it	had	a	similar	profile	to	the	
IT	morphine	with	fentanyl	PCA	group.	The	majority	of 	patients	responded	to	a	
single	rescue	dose	for	nausea	and	pruritus.	No	patients	in	any	group	experienced	
respiratory	depression	requiring	an	opioid	antagonist.	ANOVA	analysis	showed	
no	 statistical	 significance	 in	 the	 time	 to	 rescue	 between	 the	 analgesic	 groups.	
Overall,	THA	had	higher	incidence	of 	side-effects	than	TKA.
Conclusion: 
Analgesic	efficacy	must	be	considered	when	evaluating	side	effects.	Other	stud-
ies	 have	 demonstrated	 superior	 analgesic	 efficacy	with	EREM.	While	EREM	
may	have	a	higher	side	effect	profile	than	some	treatments,	the	impact	may	be	
minimal	compared	to	the	benefits	of 	better	analgesia	and	a	reduction	 in	risks	
related	 to	 other	more	 invasive	modalities.	Overall,	 the	 side-effects	 of 	EREM	
responded	to	one	rescue	dose,	supporting	minimal	patient	discomfort	and	use	
of 	healthcare	resources.
ABSTRACT
Hip Arthroplasty 
1. EREM 7.5 mg 
2. EREM 10.0 mg 
3. Combined Intrathecal morphine PF 
    with fentanyl PCA  
4. Fentanyl PCA
Knee Arthroplasty 
1. EREM 10.0 mg
2. EREM 12.5 mg
3.Indwelling epidural catheter with 0.2% 
   Ropivicaine and  fentanyl PCA 
4. Single injection femoral nerve block and 
    fentanyl PCA. 
Total Hip Arthroplasty
EREM 7.5 mg (n=40)
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Requiring Antiemetic Treatment
Time to 1st Antiemetic
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EREM 10 mg (n=17)
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IT Morphine PF + Fentanyl PCA (n=24)
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Fentanyl PCA (n=13)  
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Total Hip Arthroplasty
EREM 10 mg (n=44)
Respiratory Depression
Requiring Antiemetic Treatment
Time to 1st Antiemetic
Time to 1st Antiemetic (Standard Error of the Mean)
Requiring 2nd Antiemetic Treatment
Requiring Antihistamine Treatment
Time to 1st Antihistamine
Time to 1st Antihistamine (Standard Error of the Mean)
Requiring 2nd Antihistamine Treatment
EREM 12.5 mg (n=18)
Respiratory Depression
Requiring Antiemetic Treatment
Time to 1st Antiemetic
Time to 1st Antiemetic (Standard Error of the Mean)
Requiring 2nd Antiemetic Treatment
Requiring Antihistamine Treatment
Time to 1st Antihistamine
Time to 1st Antihistamine (Standard Error of the Mean)
Requiring 2nd Antihistamine Treatment
Indwelling Epidural Catheter with 0.2 % 
Ropivicaine + Fentanyl PCA (n=25)
Respiratory Depression
Requiring Antiemetic Treatment
Time to 1st Antiemetic
Time to 1st Antiemetic (Standard Error of the Mean)
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Requiring Antihistamine Treatment
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Requiring 2nd Antihistamine Treatment
Single Femoral Nerve Block + Fentanyl PCA (n=25)
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Postoperative Day
Table 1: Post-Operative Side Effect Profiles of Different Analgesic 
Modalities Following Total Hip Arthroplasty
Table 2: Post-Operative Side Effect Profiles of Different Analgesic 
Modalities Following Total Knee Arthroplasty
Figure 1: Post- 
operative Time to 
First Treatment for 
N a u s e a / Vo m i t i n g 
and Pruritus Opioid 
Side Effects in Total 
Hip Arthroplasty
Figure 2: Post- 
operative Time to 
First Treatment for 
Nausea/Vomiting and 
Pruritus Opioid Side 
Effects in Total Knee 
Arthroplasty
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